Renal Mass on Ultrasound: What Next?
A renal mass found on ultrasound is a description, not a diagnosis. Many findings are simple benign cysts that need no treatment, while others are complex cysts, angiomyolipomas, oncocytomas or renal cell carcinomas. Ultrasound is excellent for detecting many cysts and masses but often cannot fully define whether a solid-looking lesion truly enhances, how complex a cyst is, or how the mass relates to blood vessels and the collecting system. When the ultrasound is indeterminate or suspicious, the usual next step is a contrast-enhanced renal-mass CT or MRI. The result then guides whether the lesion can be ignored, followed, biopsied, ablated or removed.
First question: cystic or solid?
A classic simple cyst has thin smooth walls, clear fluid and no solid component. It is usually benign. A complex cyst has septa, wall thickening, calcification or solid/nodular elements and often needs contrast CT or MRI for Bosniak classification. A solid renal mass needs assessment for contrast enhancement because most clinically important solid RCCs enhance.
What should a good ultrasound report include?
- Which kidney and exact location.
- Maximum size in centimetres.
- Solid, cystic or mixed appearance.
- Echogenicity and whether macroscopic fat is suspected.
- Presence of internal septa, nodules, calcification or vascularity where assessable.
- Hydronephrosis or other urinary-tract findings.
Which scan comes next?
| Situation | Typical next test | Reason |
|---|---|---|
| Indeterminate solid mass | Contrast-enhanced renal-mass CT or MRI | Confirms enhancement and anatomy. |
| Complex cyst | Renal-mass CT or MRI | Allows Bosniak v2019 classification using enhancement and morphology. |
| Simple cyst with classic benign features | Often no further imaging | Further testing usually adds no value unless symptoms or atypical features exist. |
| Contrast contraindication / poor kidney function | MRI, contrast-enhanced ultrasound where available, or individualized protocol | Choice depends on renal function and the diagnostic question. |
Does size tell you whether it is cancer?
No. Larger solid masses are statistically more likely to be malignant and aggressive, but small masses can be cancer and large masses can occasionally be benign. Size influences treatment and stage but does not replace imaging characterization or pathology when biopsy is needed.
When is renal-mass biopsy useful?
Biopsy can help before ablation, when imaging could represent lymphoma or metastasis, or when the diagnosis would change a decision between surveillance and surgery. It is not mandatory before every nephrectomy. Biopsy has a small non-diagnostic rate and must be interpreted together with imaging.
What if the mass is small?
A solid enhancing mass up to 4 cm is a small renal mass (clinical T1a). Many are indolent and a meaningful minority are benign. Partial nephrectomy is commonly preferred when treatment is needed, but active surveillance or thermal ablation can be appropriate in selected patients.
What if the ultrasound says “complex cyst”?
Ask whether the lesion has been characterized on contrast CT or MRI and given a Bosniak category. Ultrasound alone usually cannot reliably assign all Bosniak 2019 classes, particularly categories III and IV, which depend on enhancement of walls, septa or nodules.
When is evaluation urgent?
Most incidentally discovered renal masses do not require emergency treatment. Urgent assessment is needed for heavy haematuria, severe pain with fever, significant bleeding, rapidly declining kidney function or other acute complications. Cancer work-up itself is usually deliberate rather than same-day emergency surgery.
The next scan should characterize the mass, not simply “look again”
When ultrasound finds an indeterminate solid or complex renal lesion, the next study is usually contrast-enhanced CT or MRI using a renal-mass protocol if kidney function and other factors allow. The key question is whether the lesion truly enhances with contrast and whether it is solid, fat-containing, cystic or vascular. A repeat non-contrast ultrasound may confirm size but often cannot answer these characterization questions.
Some benign lesions, such as angiomyolipoma with visible fat, can have characteristic imaging. Others, including fat-poor angiomyolipoma and oncocytoma, can mimic renal cell carcinoma. That uncertainty is one reason biopsy can be useful when its result would change surveillance, ablation or surgery.
Consultation checklist
- Ultrasound report and images if available.
- Previous ultrasound/CT for comparison — stability over years is important information.
- Creatinine/eGFR.
- Urine routine if blood was detected.
- History of kidney stones, prior cancer or renal surgery.
- Family history of kidney cancer.
- Current blood thinners.
FAQs
Can an ultrasound tell if a renal mass is cancer?
Sometimes it can confidently identify a simple cyst, but many solid or complex lesions need contrast CT or MRI for proper characterization.
Does “hypoechoic” or “hyperechoic” mean cancer?
No. Echogenicity describes ultrasound appearance and is not itself a diagnosis.
Should every renal mass be biopsied?
No. Biopsy is used when the result will change management. Many typical localized enhancing masses proceed to partial nephrectomy without preoperative biopsy.
How quickly should I get the CT or MRI?
Most incidental masses can be evaluated in a planned outpatient timeframe. Faster assessment is appropriate when the lesion is large, symptomatic, associated with venous invasion or accompanied by concerning systemic findings.
Can a renal mass disappear on repeat imaging?
Apparent masses can occasionally represent focal scarring or technical artefact, which is one reason dedicated contrast imaging is useful. A true solid enhancing tumour usually does not simply disappear.
Related reading
- Kidney Cancer: Symptoms, Diagnosis and Treatment
- Small Renal Mass Explained
- Renal Cyst vs Kidney Cancer
- Bosniak Classification Explained
- Testicular Ultrasound: What Does a Testicular Mass Mean?
- Urologist in Latur
References
- European Association of Urology (EAU). EAU Guidelines on Renal Cell Carcinoma. 2026 edition https://uroweb.org/guidelines/renal-cell-carcinoma
- National Cancer Institute. Renal Cell Cancer Treatment (PDQ®)–Patient Version https://www.cancer.gov/types/kidney/patient/kidney-treatment-pdq
- Silverman SG, Pedrosa I, Ellis JH, et al. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment. Radiology. 2019;292(2):475-488.
- American Urological Association. Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up Guideline (2017; amended 2021) https://www.auanet.org/guidelines-and-quality/guidelines/renal-mass-and-localized-renal-cancer-evaluation-management-and-follow-up